Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.

Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.

Item
http://www.wikidata.org/entity/Q38155343
New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumabBruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinibObinutuzumab: a novel anti-CD20 monoclonal antibody for previously untreated chronic lymphocytic leukemia.Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureChronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?Predictors of outcome in reduced intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: summarizing the evidence and highlighting the limitations.High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.Ibrutinib-A double-edge sword in cancer and autoimmune disorders.Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy.Antileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer.
P2860

Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.

Item
http://www.wikidata.org/entity/Q38155343
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.
@en
type
label
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.
@en
prefLabel
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P356
P1433
P1476
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921